DGTR recommends anti-dumping duty on tuberculosis ingredient imports
In short
DGTR has recommended an anti-dumping duty on a tuberculosis drug ingredient imported from China and Thailand. It says the product was sold below normal value and hurt the domestic industry.
This matters for Indian drug makers and importers. The report does not say the duty amount or whether the recommendation has become a final decision.
What the reporting says
DGTR recommended an anti-dumping duty on imports of a tuberculosis drug ingredient from China and Thailand, according to the reported summary. It found the product was exported below normal value and that this caused material injury to the domestic industry. The reporting does not state the duty rate, the ingredient name, or whether the government has issued a final order yet.
Why it matters
DGTR recommended an anti-dumping duty on a tuberculosis drug ingredient imported from China and Thailand after finding the product was exported below normal value and caused material injury to the domestic industry. That could affect importers and domestic pharmaceutical producers if a duty is imposed. The available reporting does not identify the ingredient, the duty level, or the final status of the recommendation.